Physician profile
John Burigo
NPI 1831198159
$2,349.03
in general payments reported to CMS, 2019-2025
22 companies · $479 in 2025
The $479 reported for 2025 was more than what 79% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $78.72 · 2020: $69.94 · 2021: $371 · 2022: $387 · 2023: $537 · 2024: $426 · 2025: $479.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,442.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,442.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $456.83 | 2019-2025 | |
| Astellas Pharma US INC | $299.53 | 2023-2025 | Veozah |
| Exact Sciences Corporation | $227.76 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Aspira Women'S Health INC | $226.71 | 2020-2023 | Ova1 |
| Ge Healthcare | $211.12 | 2019-2023 | |
| Gynesonics, INC. | $190.71 | 2021-2022 | |
| Meditrina | $150.00 | 2023 | |
| Hologic Sales and Service, LLC | $142.43 | 2022-2025 | Myosure Tissue Removal Device, Novasure |
| Siemens Medical Solutions USA, INC. | $131.55 | 2023-2024 | Mammomat Revelation |
| Medline Industries LP | $57.59 | 2021 | |
| Samsung Hme America, INC. | $47.50 | 2025 | |
| Therapeuticsmd, INC. | $34.18 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $32.16 | 2020-2022 | |
| Millicent US INC | $19.13 | 2025 | Femlyv |
| Duchesnay USA Incorporated | $17.00 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopersurgical, INC. | $16.54 | 2024 | Paragard T 380a |
| Evofem Biosciences, INC. | $15.94 | 2020 | |
| Agile Therapeutics, INC. | $15.69 | 2021 | |
| Uroviu Corporation | $15.27 | 2023 | Uro-G Flexible Cystoscope |
| Roche Diagnostics Corporation | $14.45 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $14.30 | 2022 | |
| Pfizer INC. | $12.64 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Burigo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.